Palliative pelvic radiotherapy for symptomatic rectal cancer – a prospective multicenter study

References

• Guren MG, Korner H, Pfeffer F, Myklebust TA, Eriksen MT, Edna TH, et al. Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010. Acta Oncol 2015;54:1–9.
   PubMed Web of Science ®Google Scholar
• Cameron MG, Kersten C, Vistad I, Fossa S, Guren MG. Palliative pelvic radiotherapy of symptomatic incurable rectal cancer - a systematic review. Acta Oncol 2014;53:164–73.
   PubMed Web of Science ®Google Scholar
• Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012;30:1926–33.
   PubMed Web of Science ®Google Scholar
• Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638–46.
   PubMed Web of Science ®Google Scholar
• Foster JD, Jones EL, Falk S, Cooper EJ, Francis NK. Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature. Dis Colon Rectum 2013;56:921–30.
   PubMed Web of Science ®Google Scholar
• Lutz ST, Jones J, Chow E. Role of radiation therapy in palliative care of the patient with cancer. J Clin Oncol 2014;32:2913–9.
   PubMed Web of Science ®Google Scholar
• Kaasa S, Hjermstad MJ, Loge JH. Methodological and structural challenges in palliative care research: how have we fared in the last decades? Palliat Med 2006;20:727–34.
   PubMed Web of Science ®Google Scholar
• Cameron MG, Kersten C, van Helvoirt R, Rohde G, Fossa SD, Vistad I. Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: a pilot study. BMC Res Notes 2011;4:252.
   PubMedGoogle Scholar
• Cameron MG, Kersten C, Vistad I, van Helvoirt R, Weyde K, Undseth C, et al. Palliative pelvic radiotherapy for symptomatic incurable prostate cancer - A prospective multicenter study. Radiother Oncol 2015;115:314–20.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76.
   PubMed Web of Science ®Google Scholar
• Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, et al. The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 1995;31A:2260–3.
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129–38.
   PubMedGoogle Scholar
• Klepstad P, Loge JH, Borchgrevink PC, Mendoza TR, Cleeland CS, Kaasa S. The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage 2002;24:517–25.
   PubMed Web of Science ®Google Scholar
• Cancer Therapy Evaluation Program D, NCI, NIH, DHHS. Common Terminology Criteria for Adverse Events, Version 3.0. 2003.
   Google Scholar
• Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139–44.
   PubMed Web of Science ®Google Scholar
• King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996;5:555–67.
   PubMed Web of Science ®Google Scholar
• Kouloulias V, Tolia M, Kolliarakis N, Siatelis A, Kelekis N. Evaluation of acute toxicity and symptoms palliation in a hypofractionated weekly schedule of external radiotherapy for elderly patients with muscular invasive bladder cancer. International Braz J Urol: Official Journal of the Brazilian Society of Urology 2013;39:77–82.
   PubMed Web of Science ®Google Scholar
• van Lonkhuijzen L, Thomas G. Palliative radiotherapy for cervical carcinoma, a systematic review. Radiother Oncol 2011;98:287–91.
   PubMed Web of Science ®Google Scholar
• Tseng YD, Krishnan MS, Sullivan AJ, Jones JA, Chow E, Balboni TA. How radiation oncologists evaluate and incorporate life expectancy estimates into the treatment of palliative cancer patients: a survey-based study. Int J Radiat Oncol Biol Phys 2013;87:471–8.
   PubMed Web of Science ®Google Scholar
• Jordhoy MS, Kaasa S, Fayers P, Ovreness T, Underland G, Ahlner-Elmqvist M. Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial. Palliat Med 1999;13:299–310.
   PubMed Web of Science ®Google Scholar
• Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutrition Journal 2010;9:69.
   PubMed Web of Science ®Google Scholar
• Sorbye H. Palliative chemotherapy in elderly patients with metastatic colorectal cancer: do we know how it should be used? Acta Oncol 2012;51:819–21.
   PubMed Web of Science ®Google Scholar
• Zhou ZR, Liu SX, Zhang TS, Chen LX, Xia J, Hu ZD, et al. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis. Surg Oncol 2014;23:211–21.
   PubMed Web of Science ®Google Scholar
• Duchesne GM, Bolger JJ, Griffiths GO, Trevor Roberts J, Graham JD, Hoskin PJ, et al. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09. Int J Radiat Oncol Biol Phys 2000;47:379–88.
   PubMed Web of Science ®Google Scholar
• Tyc-Szczepaniak D, Wyrwicz L, Kepka L, Michalski W, Olszyna-Serementa M, Palucki J, et al. Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: a phase II study. Ann Oncol 2013;24:2829–34.
   PubMed Web of Science ®Google Scholar